(NYSE: BLCO) Bausch & Lomb's forecast annual revenue growth rate of 6.07% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 9.17%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.79%.
Bausch & Lomb's revenue in 2026 is $5,208,000,000.On average, 15 Wall Street analysts forecast BLCO's revenue for 2026 to be $1,988,403,268,566, with the lowest BLCO revenue forecast at $1,905,330,297,152, and the highest BLCO revenue forecast at $2,055,432,103,870. On average, 15 Wall Street analysts forecast BLCO's revenue for 2027 to be $2,101,068,757,694, with the lowest BLCO revenue forecast at $1,997,316,677,516, and the highest BLCO revenue forecast at $2,173,445,638,368.
In 2028, BLCO is forecast to generate $2,216,230,001,328 in revenue, with the lowest revenue forecast at $2,089,659,594,238 and the highest revenue forecast at $2,297,520,290,952.